NCT06217770View on ClinicalTrials.gov

Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment

CompletedOBSERVATIONAL
Enrollment

237

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

January 4, 2024

Study Completion Date

January 4, 2024

Conditions
Prostate Cancer
Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

Chinese University of Hong Kong

OTHER

NCT06217770 - Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment | Biotech Hunter | Biotech Hunter